Home  
  Our Team  
  Patient Info  
  Services  
   
  Pay My Bill  
  Contact Us  

News for Healthier Living

Pivotal SPRAY-CB Trial of RejuvenAir(r) Published in American Journal of Respiratory and Critical Care Medicine

CSA Medical, Inc., a medical device company focused on interventional pulmonary therapies, today announced the publication in the American Journal of Respiratory and Critical Care Medicine (AJRCCM) of results from SPRAY-CB (NCT03893370), the pivotal randomized, blinded, sham-controlled trial evaluating Metered CryoSpray(tm) (MCS) therapy with the RejuvenAir(r) System in patients with moderate-to-severe COPD and symptomatic chronic bronchitis.

September 23, 2026


September 23 2026

September 22 2026

September 21 2026

September 18 2026

September 17 2026

September 16 2026

September 15 2026

September 14 2026

September 11 2026

September 10 2026

September 9 2026